The table below shows ATOSSA THERAPEUTICS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$9.58M
-$5.96M
-$4.70M
-$7.02M
-$4.88M
-$4.41M
Capital expenditure
$0.00
$9.00K
$6.00K
$0.00
$13.00K
$0.00
Investing cash flow
$0.00
-$9.00K
-$6.00K
$0.00
-$13.00K
$0.00
Dividends paid
-
-
-
-
ATOS operating cash flow (10-K history)
ATOSSA THERAPEUTICS, INC. reported operating cash flow of -$29.76M for fiscal year 2025. That is down 41.5% from -$21.03M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.37M (FY 2016) to -$29.76M. Figures come from the company's audited annual reports as filed with the SEC.